Location of Repository

L-Cysteine Administration Attenuates Pancreatic Fibrosis Induced by TNBS in Rats by Inhibiting the Activation of Pancreatic Stellate Cell

By LiJuan Yang, JiaQing Shen, ShanShan He, GuoYong Hu, Jie Shen, Feng Wang, Ling Xu, WeiQi Dai, Jie Xiong, JianBo Ni, ChuanYong Guo, Rong Wan and XingPeng Wang
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3281011
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (2004). Mechanisms of pancreatic fibrosis.
    2. (1999). Diagnosis of chronic pancreatitis: is a gold standard necessary?
    3. (2002). Conservative management of chronic pancreatitis.
    4. (2002). Interventional treatment of chronic pancreatitis.
    5. (2003). EUS-guided celiac plexus neurolysis and celiac plexus block.
    6. (2002). Surgical treatment and long-term follow up in chronic pancreatitis.
    7. (2010). High-dose naproxen aggravates pancreatic fibrosis in a rat model of chronic pancreatitis.
    8. (2000). Repetitive acute pancreatic injury in the mouse induces procollagen alpha1(I) expression colocalized to pancreatic stellate cells.
    9. (1999). Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis.
    10. (2000). Collagen type I synthesized by periacinar stellate cells (PSC) co-localizes with lipid peroxidationderived aldehydes in chronic alcoholic pancreatitis.
    11. (1998). Over expression of platelet derived growth factor (PDGF) B chain and type B PDGF receptor in human chronic pancreatitis.
    12. (2008). Pancreatic stellate cells: New target in the treatment of chronic pancreatitis.
    13. (2001). Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells.
    14. (2000). TGF-b1 autocrine growth control in isolated pancreatic fibroblast cells/stellate cells in vitro.
    15. (1986). Sulfur amino acid metabolism in chronic relapsing pancreatitis.
    16. (2005). Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine.
    17. (2000). Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells.
    18. (2003). L-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activation.
    19. (1996). Induction of chronic pancreatic disease by trinitrobenzene sulfonic acid infusion into rat pancreatic ducts.
    20. (1999). Ethanol feeding aggravates morphological and biochemical parameters in experimental chronic pancreatitis.
    21. (1996). A simplified method for the analysis of hydroxyproline in biological tissues.
    22. (1998). Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture.
    23. (1997). Pancreatic acinar cells produce, release, and respond to tumor necrosis factoralpha. Role in regulating cell death and pancreatitis.
    24. (2006). Cell death in pancreatitis: caspases protect from necrotizing pancreatitis.
    25. (2010). Reg4 protects against acinar cell necrosis in experimental pancreatitis.
    26. (2011). Alterations in plasma amino acid levels in chronic pancreatitis.
    27. (2004). Sulfurcontaining amino acids attenuate the development of liver fibrosis in rats through down-regulation of stellate cell activation.
    28. (2005). Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype.
    29. (1999). Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis.
    30. (2000). Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis.
    31. (2002). Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells.
    32. (1996). Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice.
    33. (2005). Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling.
    34. (1985). The regulation of hepatic glutathione.
    35. (1974). Studies on the regulation of glutathione level in rat liver.
    36. (1977). The role of methionine in glutathione biosynthesis by isolated hepatocytes.
    37. (2006). Influence of selenium treatment on the acute toxicity of dibutylin dichloride in rats.
    38. (2006). Overexpression of redox-active protein thioredoxin-1 prevents development of chronic pancreatitis in mice.
    39. (2007). Allopurinol in rat chronic pancreatitis: effects on pancreatic stellate cell activation.
    40. (2006). Long-term high-fat diet induces pancreatic injuries via pancreatic microcirculatory disturbances and oxidative stress in rats with hyperlipidemia.
    41. (2002). Xanthine oxidase Y derived oxygen radicals play significant roles in the development of chronic pancreatitis in wbn/kob rats.
    42. (2006). Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis.
    43. (2009). A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis.
    44. (2005). Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model.
    45. (2008). Pancreatic stellate cells: molecular mechanism of pancreatic fibrosis.
    46. (2003). Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellularmatrix turnover. Gut 52: 275–282. L-Cysteine Attenuates Pancreatic Fibrosis
    47. (2003). Pancreas: healing response in critical illness.
    48. (2001). Menke A
    49. (2002). Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.
    50. (1997). Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
    51. (2008). Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis.
    52. (2001). High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.
    53. (2002). A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway.
    54. (2005). Nrf2, a multi-organ protector?
    55. (2010). Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullinring ubiquitin ligases.
    56. (2010). Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway.
    57. (2006). Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis.
    58. (2010). Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis.
    59. (2007). The pancreatic stellate cell: a star on the rise in pancreatic diseases.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.